November 18, 2016 - By Dolores Ford · 0 Comments
The stock of Vbi Vaccines New (NASDAQ:VBIV) registered an increase of 22.53% in short interest. VBIV’s total short interest was 170,200 shares in November as published by FINRA. Its up 22.53% from 138,900 shares, reported previously. With 95,200 shares average volume, it will take short sellers 2 days to cover their VBIV’s short positions. About 26,470 shares traded hands. VBI Vaccines, Inc. – Ordinary Shares (NASDAQ:VBIV) has risen 6.00% since October 19, 2016 and is uptrending. It has outperformed by 1.57% the S&P500.
Out of 2 analysts covering VBI Vaccines (NASDAQ:VBIV), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. VBI Vaccines has been the topic of 2 analyst reports since July 26, 2016 according to StockzIntelligence Inc. The stock of VBI Vaccines, Inc. – Ordinary Shares (NASDAQ:VBIV) earned “Buy” rating by Laidlaw on Monday, October 10. The company was initiated on Tuesday, July 26 by Ladenburg Thalmann.
Another recent and important VBI Vaccines, Inc. – Ordinary Shares (NASDAQ:VBIV) news was published by Seekingalpha.com which published an article titled: “VBI Vaccines Is In Line For Investment Reallocation Boost From Novavax’s …” on September 28, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Dolores Ford
Tags: Ordinary Shares